Varicella-Zoster Virus Diagnostic Market: By Drug Type, By Based on the Route of Administration, By Distribution Channel, and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Varicella-Zoster Virus (VZV) Diagnostic Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Type (Acyclovir, Valacyclovir, Famciclovir, and Others), By Based on the Route of Administration (Oral, Injectable, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-commerce), and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Varicella-Zoster Virus (VZV) Diagnostic Market held a significant market share during the forecast period. Preventing varicella zoster infection through vaccination strategies avoids the primary infections in neonates and vulnerable cases. The increasing risk of postnatal varicella zoster infection in children less than 1 year of age will use acyclovir as the first line of treatment for these infected children will drive the growth of the market in the future. The increasing incidences of viral-borne disease among children and the old population, high transmission rate of the infection, high occurrence of infections in low or middle-income countries, and growing revenue of the market players are the major factors contributing to the growth of the varicella-zoster infection treatment market.

Moreover, the companies are focusing on organic and inorganic growth by introducing their products and gaining maximum market share.  In addition, acquisitions, expansion of product portfolio, and research & development capabilities are predicted to create opportunities for the growth of the market. However, to ensure safety and accuracy, the development and commercialization of viral antigen diagnostic tests must stick to strict regulatory requirements. There may be a significant barrier for both established companies and start-ups in the global viral antigen diagnostics market to comply with the regulations and quality control standards.

Varicella-Zoster Virus (VZV) Diagnostic Market Key Developments:
  • In July 2021, US Food and Drug Administration (FDA) authorized posoleucel (Viralym-M, ALVR105) as an orphan drug designation (ODD) for the treatment of hemorrhagic cystitis (HC) which is caused by viruses.
  • In April 2017, U.S. FDA approved the Mylan pharmaceuticals which is the subsidiary of Mylan Inc for acyclovir ointment USP, the zovirax ointment is the first generic version of Valeant International.
  • In December 2016, The slayback made an agreement with Sandoz for the sale and marketing rights of slayback Generic Zovirax Ointment (Acyclovir Ointment) due to which the Novartis position augmented in the market by getting the rights of sales and marketing.
  • In Dec 2015, valeant pharmaceuticals, Inc. agreed with walgreens which helped the company foray into the pharmaceutical retail business.

summary download arrow Download Free Sample

Varicella-Zoster Virus Diagnostic Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

x%

Largest Market

North America

Fastest Growing Market

North America

Varicella-Zoster Virus (VZV) Diagnostic Market Dynamics

The varicella treatment market is expanding as a result of rising awareness of the benefits of using vaccinations. Outbreaks of varicella are nevertheless frequent and increasingly happen in populations with high vaccination rates. Those who have had vaccinations usually experience minor breakout varicella, with fewer lesions that often do not develop into vesicles. As a result, varicella laboratory diagnosis has become more crucial, especially in situations where an outbreak is occurring. In temperate-climate countries, varicella was virtually a childhood infection that everyone contracted before the vaccine era; by the time a person turned 20, around 98% of Americans had tested positive for VZV.  Enhancing individual and societal acceptability of varicella vaccine would lessen the disease's negative effects on children's health and the availability of medical resources.

Varicella-Zoster Virus Diagnostic Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market CAGR

x%

By Drug Type

  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • Others

By Route of Administration

  • Oral
  • Injectable
  • Topical

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-commerce

Key Features of the Report

  • The varicella-zoster virus (vzv) diagnostic market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Novartis, Astrazeneca, Pfizer, Abbott Laboratories, Sun Pharmaceuticals Ltd are the key producers of VZV drugs.

Historic years considered for the market study are 2019 through 2022, 2023 is considered as the base year for market estimation and the forecast presented from 2024 to 2030.

US, China, Japan, Germany and the UK are the top 5 companies driving demand for Varicella Zoster.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Varicella-Zoster Virus Diagnostic Market Introduction 
2.1.Global Varicella-Zoster Virus Diagnostic Market  - Taxonomy
2.2.Global Varicella-Zoster Virus Diagnostic Market  - Definitions
2.2.1. By Drug Type
2.2.2. By Route of Administration
2.2.3. By Distribution Channel
2.2.4. By Region
3.Global Varicella-Zoster Virus Diagnostic Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Varicella-Zoster Virus Diagnostic Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Varicella-Zoster Virus Diagnostic Market  By Drug Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Acyclovir
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Valacyclovir
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Famciclovir
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Varicella-Zoster Virus Diagnostic Market  By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Injectable
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Topical
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Varicella-Zoster Virus Diagnostic Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital Pharmacy
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacy
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. E-commerce
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Varicella-Zoster Virus Diagnostic Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Varicella-Zoster Virus Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Acyclovir
9.1.2.Valacyclovir
9.1.3.Famciclovir
9.1.4.Others
9.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral
9.2.2.Injectable
9.2.3.Topical
9.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacy
9.3.2.Retail Pharmacy
9.3.3.E-commerce
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Varicella-Zoster Virus Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Acyclovir
10.1.2.Valacyclovir
10.1.3.Famciclovir
10.1.4.Others
10.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Injectable
10.2.3.Topical
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacy
10.3.2.Retail Pharmacy
10.3.3.E-commerce
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Varicella-Zoster Virus Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Acyclovir
11.1.2.Valacyclovir
11.1.3.Famciclovir
11.1.4.Others
11.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Injectable
11.2.3.Topical
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacy
11.3.2.Retail Pharmacy
11.3.3.E-commerce
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Varicella-Zoster Virus Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Acyclovir
12.1.2.Valacyclovir
12.1.3.Famciclovir
12.1.4.Others
12.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Injectable
12.2.3.Topical
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacy
12.3.2.Retail Pharmacy
12.3.3.E-commerce
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Varicella-Zoster Virus Diagnostic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Acyclovir
13.1.2.Valacyclovir
13.1.3.Famciclovir
13.1.4.Others
13.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Injectable
13.2.3.Topical
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacy
13.3.2.Retail Pharmacy
13.3.3.E-commerce
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Roche
14.2.2.Sun Pharmaceuticals Ltd
14.2.3.Dr Reddy’s Laboratories Ltd
14.2.4.Valeant Pharmaceuticals international Inc.
14.2.5.Teva Pharmaceuticals Industries Ltd
14.2.6.Mylan N. V.
14.2.7.Merck
14.2.8.Pfizer
14.2.9.Novartis
14.2.10.Abbott Laboratories
14.2.11.GlaxoSmithKline
14.2.12.Sanofi
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Roche
  • Sun Pharmaceuticals Ltd
  • Dr Reddy’s Laboratories Ltd
  • Valeant Pharmaceuticals international Inc.
  • Teva Pharmaceuticals Industries Ltd
  • Mylan N. V.
  • Merck
  • Pfizer
  • Novartis
  • Abbott Laboratories
  • GlaxoSmithKline
  • Sanofi
  • Eli Lilly
  • Astrazeneca
  • Johnson & Johnson.

Related Industry Reports

Global Molecular Diagnostics Market

Global Infectious Disease Point Of Care Diagnostics Market

Global Infectious Disease Diagnostics Market

Global Cytomegalovirus Diagnostics Market